India Pharma Outlook team | Monday, 22 April 2024
Mac-Chem Products (India) Pvt. Ltd. (Mac-Chem) announced today the successful renewal of its European Union Goods Manufacturing Practices) (EU-GMP) certification for its manufacturing facility in Boisar. The approval marks a significant milestone for Mac-Chem in its journey of global leadership. The audit was conducted in October 2023 by Swissmedic Swiss Agency for Therapeutic Products.
Speaking on the development, Mr. Manish Jain, Director at Mac-Chem said, “We are delighted with the successful renewal of our EU-GMP certification. The achievement affirms our commitment to the highest standards of quality and compliance aligning with the European regulations. The timely approval further reaffirms our commitment for delivering high-quality pharma products that positively impact patient care globally.”
The EU-GMP certification underlines the Boisar facility’s capabilities to ensure consistent and controlled production in accordance with EU quality standards. The facility produces a wide range of APIs, with a special focus on oncology and other niche specialty segments.